FIRM FIXED PRICE

FERRING PHARMACEUTICALS INC - ADSTILADRIN (NADOFARAGENE FIRADENOVEC)

PIID: 36C24526N0103
Signed Date: Oct 17, 2025Effective Date: Oct 17, 2025End Date: Closed on Oct 21, 2025
Award $
$46K
Vendor
FERRING PHARMACEUTICALS INC
NAICS
325412
Signed Date
Oct 17, 2025

Key Details

Dollars Obligated
$45,829.15
Base & All Options
$45,829.15
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
CARROLLTON, TX, 750105022, CD-TX-26

Description

ADSTILADRIN (NADOFARAGENE FIRADENOVEC)

Context & Analysis

On Oct 17, 2025, Department of Veterans Affairs obligated $45,829.15 to FERRING PHARMACEUTICALS INC for adstiladrin (nadofaragene firadenovec). The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in CARROLLTON, TX. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: D6ATBE6Y96L5
CAGE Code: 4MV33
Location: PARSIPPANY, NJ

Stay Updated

Get notified about new opportunities matching your interests.

Related